Quanta Services Inc. (NYSE: PWR) has reported earnings for its fourth fiscal quarter (ending December 31) of $2.06 versus $1.45 for the same period a year ago — an increase of 42%. For the latest […]
IDACORP Inc. (NYSE: IDA) has reported E.P.S. of $0.69 for its fourth fiscal quarter (ending December 31) versus $0.62 for the same period a year ago — an increase of 11%. For the latest four […]
On 2/20/25, Herbalife Nutrition Ltd (NYSE: HLF) stock enjoyed a major increase of 42.7%, closing at $8.02. Moreover, exceptionally high trading volume at 854% of normal accompanied the advance. The stock has risen 53.1% during […]
HNI Corp (NYSE: HNI) has reported E.P.S. of $0.81 for its fourth fiscal quarter (ending December 31) versus $0.49 for the same period a year ago — an increase of 65%. For the latest four […]
For its fourth fiscal quarter (ending December 31), Globant SA (NYSE: GLOB) has reported a -10% decline in E.P.S. from $0.98 a year ago to $0.88 in the current quarter. For the latest four quarters […]
Glaukos Corp (NYSE: GKOS) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.60 versus a loss $-0.75 for the same period a year ago — a decline of -20%. For […]
For its fourth fiscal quarter (ending December 31), Forum Energy Technologies Inc (NYSE: FET) has reported a 412% increase in E.P.S. from $-1.64 a year ago to $-8.39 in the current quarter. For the latest […]
FTI Consulting Inc. (NYSE: FCN) stock closed at $162.99 on 2/20/25 after a major decline of -14.3%. Moreover, trading volume in this decline was exceptionally high at 343% of normal. Relative to the market the […]
EPAM Systems Inc (NYSE: EPAM) has reported E.P.S. of $1.82 for its fourth fiscal quarter (ending December 31) versus $1.69 for the same period a year ago — an increase of 8%. For the latest […]
Choice Hotels International Inc. (NYSE: CHH) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.62 versus $0.58 for the same period a year ago — an increase of 179%. E.P.S. were […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research